HLD200 regulatory update

FDA accepted for review an NDA from Highland’s Ironshore Pharmaceuticals & Development Inc. subsidiary for HLD200 to treat ADHD. The PDUFA date is July 30, 2017. Benjorna is a modified-release formula...